Literature DB >> 21906410

The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000-2008.

D Y Chao1, Y Z Chien, Y P Yeh, P S Hsu, I B Lian.   

Abstract

The introduction and the widespread use of the varicella vaccine in Taiwan has led to a 75-80% decrease in the incidence of varicella in children. However the vaccine's long-term impact on the incidence of herpes zoster (HZ) has attracted attention. By controlling gender, underlying diseases, and age effects, a Poisson regression was applied on the 2000-2008 chart records of 240 000 randomly selected residents who enrolled in the Universal National Health Insurance. The results show that, as the vaccine coverage in children increases, the incidence of varicella decreases. However, the incidence of HZ increased even before the implementation of the free varicella vaccination programme in 2004, particularly in females. The increase in the incidence of HZ cannot be entirely and directly attributed to the widespread vaccination of children. Continuous monitoring is needed to understand the secular trends in HZ before and after varicella vaccination in Taiwan and in other countries.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21906410     DOI: 10.1017/S0950268811001786

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  30 in total

1.  Varicella vaccination programs do not seem to shift the age of disease to older age groups.

Authors:  Manuel García Cenoz
Journal:  Transl Pediatr       Date:  2014-10

Review 2.  Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults.

Authors:  Kristine Macartney; Anita Heywood; Peter McIntyre
Journal:  Cochrane Database Syst Rev       Date:  2014-06-23

3.  Increasing Incidence of Herpes Zoster Over a 60-year Period From a Population-based Study.

Authors:  Kosuke Kawai; Barbara P Yawn; Peter Wollan; Rafael Harpaz
Journal:  Clin Infect Dis       Date:  2016-05-08       Impact factor: 9.079

Review 4.  Cost-effectiveness of vaccination against herpes zoster.

Authors:  Pieter T de Boer; Jan C Wilschut; Maarten J Postma
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

5.  Population-based study of the epidemiology of herpes zoster in Korea.

Authors:  You Jeong Kim; Chang Nam Lee; Chi-Yeon Lim; Woo Seok Jeon; Young Min Park
Journal:  J Korean Med Sci       Date:  2014-11-21       Impact factor: 2.153

Review 6.  Varicella vaccination - the global experience.

Authors:  Peter Wutzler; Paolo Bonanni; Margaret Burgess; Anne Gershon; Marco Aurélio Sáfadi; Giacomo Casabona
Journal:  Expert Rev Vaccines       Date:  2017-07-13       Impact factor: 5.217

7.  Herpes Zoster and Postherpetic Neuralgia: Changing Incidence Rates From 1994 to 2018 in the United States.

Authors:  Ryan R Thompson; Christina L Kong; Travis C Porco; Eric Kim; Caleb D Ebert; Nisha R Acharya
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 9.079

8.  Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster: a population-based study from primary care in Madrid (Spain).

Authors:  María D Esteban-Vasallo; M Felicitas Domínguez-Berjón; Ruth Gil-Prieto; Jenaro Astray-Mochales; Angel Gil de Miguel
Journal:  Hum Vaccin Immunother       Date:  2014-05-07       Impact factor: 3.452

9.  Examination of links between herpes zoster incidence and childhood varicella vaccination.

Authors:  Craig M Hales; Rafael Harpaz; M Riduan Joesoef; Stephanie R Bialek
Journal:  Ann Intern Med       Date:  2013-12-03       Impact factor: 25.391

10.  Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians.

Authors:  Benson Ogunjimi; Evelien Smits; Steven Heynderickx; Johan Van den Bergh; Joke Bilcke; Hilde Jansens; Ronald Malfait; Jose Ramet; Holden T Maecker; Nathalie Cools; Philippe Beutels; Pierre Van Damme
Journal:  Clin Vaccine Immunol       Date:  2014-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.